Fosun Pharma, TPG make China healthcare move

Take-private bid for Chindex offers US private equity group exposure to China's burgeoning healthcare sector.

Denise Wee

February 18, 2014

Shanghai Fosun Pharmaceutical (Fosun Pharma) and US private equity firm TPG have made an offer to take Nasdaq-listed healthcare company Chindex private in a $369 million deal.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

M&A
North Asia

#fosun pharma
#tpg
#chindex